By Conjoint Professor Dedee Frances Murrell

Journal articles

Gooderham M; Torres T; Imafuku S; Rademaker M; Prajapati VH; Tsianakas A; Murrell DF; Owczarek W; Han Y; Lee WJ; Levy G; Ibrahim N; Moreira A; Shams K, 2025, 'Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: Results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)', British Journal of Dermatology, 193, pp. 1101 - 1111, http://dx.doi.org/10.1093/bjd/ljaf236

Akbarialiabad H; Pasdar A; Murrell DF; Mostafavi M; Shakil F; Safaee E; Leachman SA; Haghighi A; Tarbox M; Bunick CG; Grada A, 2025, 'Enhancing randomized clinical trials with digital twins', Npj Systems Biology and Applications, 11, http://dx.doi.org/10.1038/s41540-025-00592-0

Akbarialiabad H; Salehi S; Murrell DF; Jafferany M, 2025, 'Morgellons disease: a review on current evidence and the need for consensus, standardized criteria, and future randomized controlled trials', Archives of Dermatological Research, 317, http://dx.doi.org/10.1007/s00403-025-04308-6

Lee H; Cowan TL; Huang C; Wilson A; Koszegi B; Stone C; Ng J; Sarsam S; Akbarialiabad H; Johal JS; Murrell OGC; Wittal RA; Murrell DF; Daniel BS, 2025, 'Pilot Study of Tildrakizumab in the Treatment of Stable Non-Segmental Vitiligo', JEADV Clinical Practice, 4, pp. 1140 - 1145, http://dx.doi.org/10.1002/jvc2.70113

Murrell DF, 2025, 'Pioneers in Dermatology and Venereology: An interview with Professor Dedee F. Murrell', Journal of the European Academy of Dermatology and Venereology, 39, pp. 2032 - 2036, http://dx.doi.org/10.1111/jdv.70132

Heyworth A; Stark M; Murrell D, 2025, 'Scoring systems for Mucous Membrane Pemphigoid – A review of the literature', SKINdeep, 1, http://dx.doi.org/10.1553/skindeep.2025.162540

Akbarialiabad H; Pasdar A; Murrell DF; Mostafavi M; Shakil F; Safaee E; Leachman SA; Haghighi A; Tarbox M; Bunick CG; Grada A, 2025, 'Erratum: Author Correction: Enhancing randomized clinical trials with digital twins (NPJ systems biology and applications (2025) 11 1 DOI: 10.1038/s41540-025-00592-0.)', Npj Systems Biology and Applications, 11, pp. 124, http://dx.doi.org/10.1038/s41540-025-00609-8

Syed A; Sarsam S; Serquina B; Murrell DF, 2025, 'A review of scoring instruments for the assessment of disease severity in epidermolysis bullosa acquisita', Dermatologica Sinica, 43, pp. 259 - 266, http://dx.doi.org/10.4103/ds.DS-D-25-00105

Sarsam S; He A; Murrell DF, 2025, 'Ofatumumab for the management of refractory pemphigus vulgaris: A case series', Jaad International, 22, pp. 94 - 96, http://dx.doi.org/10.1016/j.jdin.2025.05.018

Tseng H; Murrell DF; Turki K, 2025, 'The Bipedicled Flap for Anterior Ingrown Toenail', Dermatologic Surgery, Publish Ahead of Print, http://dx.doi.org/10.1097/DSS.0000000000004866

Stark M; Lara Rivero AD; Murrell DF, 2025, 'Photoallergic drug eruption secondary to oral terbinafine prescribed for management of tinea incognita', SKINdeep, 1, http://dx.doi.org/10.1553/skindeep.2025.153393

Wong PC; Akbarialiabad H; Wang MA; Ng TJ; Wilson A; Shulruf B; Murrell DF, 2025, 'Evaluation of the responsiveness of the Keratosis Pilaris Investigator Global Assessment Score (KP-IGA) and composite KP Area Index (KPAI)', British Journal of Dermatology, 193, pp. 556 - 558, http://dx.doi.org/10.1093/bjd/ljaf163

Aung T; Noakes R; Kasem K; Murrell DF, 2025, 'Linear Focal Elastosis: What We Know From Epidemiological Studies', Australasian Journal of Dermatology, 66, pp. 364 - 368, http://dx.doi.org/10.1111/ajd.14569

Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Murrell DF; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Salavastru C; Koumaki D; Suru A; Yordanova IA; Zemskov S; Tsymbaliuk R; Ostapko O; Augustin M; Abeni D; Szepietowski JC; Jemec GB, 2025, 'Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts', International Journal of Dermatology, 64, pp. 1546 - 1557, http://dx.doi.org/10.1111/ijd.17668

Bruckner AL; Murrell D; Lee LW; Sprecher E; Kiritsi D; Maher L; Löwe S; Donovan M; Kern JS, 2025, 'Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel-S10', Journal of Dermatology, 52, pp. 1447 - 1451, http://dx.doi.org/10.1111/1346-8138.17884

Niknam N; Akbarialiabad H; Farjoud Kouhanjani M; Kolaparambil Varghese LJ; Berrington de González A; Melin MM; Shafie’ei M; Mousavi SM; Hosseini SA; Taha SR; Russomano T; Murrell DF; Grada A; Leachman SA; Akbari Z; Derisi AJ; Jurga M; Kumar A; Das S; D’Urbano J; Hakim G; Sadeghian N; Paydar S; Tarbox M; West C; Ghorashi SM; Hosseini SH; Squire T; Bunick CG; Christiansen R, 2025, 'Space Oncology: A Comprehensive Scoping Review', Wilderness and Environmental Medicine, 36, pp. 148 - 171, http://dx.doi.org/10.1177/10806032251349442

Murrell D, 2025, 'Dr. Dedee Murrell', The Nishinihon Journal of Dermatology, 87, pp. 369 - 370, http://dx.doi.org/10.2336/nishinihonhifu.87.369

Sarsam S; Stevenson A; Murrell DF, 2025, 'The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related Pruritus', Australasian Journal of Dermatology, 66, pp. 309 - 311, http://dx.doi.org/10.1111/ajd.14530

Cascio Ingurgio R; Alfano A; Gargiulo L; Ibba L; Narcisi A; Satgé F; Stark M; Costanzo A; Murrell DF, 2025, 'Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two Centres', Australasian Journal of Dermatology, 66, pp. 305 - 308, http://dx.doi.org/10.1111/ajd.14532

Sarsam S; Koszegi BJ; Murrell DF, 2025, 'Colchicine as a treatment option for inherited epidermolysis bullosa', Clinical and Experimental Dermatology, 50, pp. 1238 - 1240, http://dx.doi.org/10.1093/ced/llaf016

Murrell DF; Bodemer C; Bruckner AL; Cunningham T; Davis C; Fernández MF; Kiritsi D; Maher L; Sprecher E; Torres-Pradilla M; Kern JS, 2025, 'Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study', British Journal of Dermatology, 192, pp. 1007 - 1017, http://dx.doi.org/10.1093/bjd/ljaf022

Salamon G; Strobl S; Field-Werners U; Welponer T; Murrell DF; Diem A, 2025, 'Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire', Journal of Health Psychology, 30, pp. 1476 - 1490, http://dx.doi.org/10.1177/13591053231221369

Akbarialiabad H; Jamshidi P; Callen JP; Murrell DF, 2025, 'Dermatologic manifestations of hereditary hemochromatosis: A systematic review', Journal of the European Academy of Dermatology and Venereology, 39, pp. 976 - 986, http://dx.doi.org/10.1111/jdv.20098

Tanemura C; Nunotani M; Kawabata K; Morooka Y; Yamagami J; Kakuta R; Saito Y; Kurihara Y; Takahashi H; Ishii N; Koga H; Nakama T; Hayashi D; Hiroyasu S; Tateishi C; Tsuruta D; Murrell DF; Hashimoto T, 2025, 'Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires', Journal of Dermatology, 52, pp. 812 - 830, http://dx.doi.org/10.1111/1346-8138.17707

Akbarialiabad H; Jamshidi P; Aminzade Z; Azizi N; Taha SR; Sadeghian N; Varghese LJK; Kouhanjani MF; Niknam N; Babocs D; El-Assaad F; Russomano T; Murrell DF; Paydar S; Bunick CG; Christiansen R; Mark Melin M, 2025, 'Leveraging space innovations for cancer breakthroughs on Earth', Trends in Cancer, 11, pp. 433 - 440, http://dx.doi.org/10.1016/j.trecan.2025.02.003

Wang MA; Wilson A; Boucher D; Johal JS; Rosenthal NK; Cowan T; Koszegi B; Lara Rivero AD; Daniel BS; Martin LK; Kern JS; Murrell DF, 2025, 'The development and validation of an investigator global assessment score for keratosis pilaris', Journal of the European Academy of Dermatology and Venereology, 39, pp. e350 - e352, http://dx.doi.org/10.1111/jdv.20326

Karakioulaki M; Dunn P; Murrell DF; Payne A; Schmidt E; Werth V; Yale M; Yamagami J; Aoki V; Borradori L; Caux F; Culton D; Daneshpazhooh M; De D; Fairley J; Hammers C; Hertl M; Holtsche M; Joly P; Koga H; Maverakis E; Mosam A; Pan M; Pincelli C; Saleh MA; Sinha AA; Solimani F; Sprecher E; Tasanen K; Tull TJ; Van Beek N; Vielmuth F; Yayli S; Patsatsi A, 2025, 'Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece', Jid Innovations, 5, http://dx.doi.org/10.1016/j.xjidi.2024.100339

Walter S; Murrell DF; Pratama R; Kizny Gordon AE; McIver CJ, 2025, 'Assessment of a Real-Time PCR Assay for the Detection of Dermatophytosis by Sampling With an Adhesive Tape Technique', Australasian Journal of Dermatology, 66, pp. e60 - e61, http://dx.doi.org/10.1111/ajd.14415

Zhou AE; Jain NP; Gronbeck C; Sloan B; Murrell DF; Grant-Kels JM, 2025, 'Ethics of publication mills and payment for guaranteed authorships', Journal of the American Academy of Dermatology, 92, pp. 666 - 667, http://dx.doi.org/10.1016/j.jaad.2024.10.034

Walter S; Murrell DF, 2025, 'Toward gender equity for all members of the academic dermatology community', Clinics in Dermatology, 43, pp. 248 - 250, http://dx.doi.org/10.1016/j.clindermatol.2025.01.004

He A; Koszegi B; Uzun S; Bilgic A; Bozca BC; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Kakuta R; Takahashi H; Nery D; Mundin C; Ramirez-Quizon M; Culton D; McAlpine S; Johal J; Shulruf B; Stone JH; Murrell DF, 2025, 'Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy', Journal of the European Academy of Dermatology and Venereology, 39, pp. 340 - 349, http://dx.doi.org/10.1111/jdv.20149

Murrell DF, 2025, 'Body image disturbance has severe psychosocial impacts in patients suffering from autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 39, pp. 253 - 254, http://dx.doi.org/10.1111/jdv.20491

Werth VP; Murrell DF; Joly P; Ardeleanu M; Hultsch V, 2025, 'Bullous pemphigoid burden of disease, management and unmet therapeutic needs', Journal of the European Academy of Dermatology and Venereology, 39, pp. 290 - 300, http://dx.doi.org/10.1111/jdv.20313

Stark M; Sheriff T; Murrell DF, 2025, 'Efficacy of adalimumab for Hailey-Hailey disease demonstrated by reduction of the Pemphigus Disease Area Index', Jaad Case Reports, 56, pp. 87 - 89, http://dx.doi.org/10.1016/j.jdcr.2024.11.025

Yang A; Sarsam S; Murrell DF, 2025, 'Linear IgA Bullous Dermatosis in Adults and Children: A Narrative Review of Literature on Disease Distribution and Evaluation of Existing Scoring Tools', Acta Dermatovenerologica Croatica, 33

Murrell DF; Bodán R; Kern JS, 2025, 'Oleogel-S10 (birch bark extract) for the treatment of epidermolysis bullosa: plain language summary of the EASE study', Future Rare Diseases, 5, http://dx.doi.org/10.1080/23995270.2025.2591643

Krastev D; Drenovska K; Shahid M; Valeva E; Ren Z; Murrell D; Vassileva S, 2025, '121 Quality of life in Bulgarian patients with autoimmune blistering diseases: ABQOL & TABQOL validation', Journal of Investigative Dermatology, 145, pp. S287 - S287, http://dx.doi.org/10.1016/j.jid.2025.10.125

Bruckner A; Kiritsi D; Murrell D; Lee LW; Sprecher E; Maher L; Löwe S; Kern J, 2025, '124: Oleogel-S10 reduces dressing changes burden and associated costs in patients with epidermolysis bullosa', Journal of Investigative Dermatology, 145, pp. e30, http://dx.doi.org/10.1016/j.jid.2025.02.127

Tseng H; Frew J; Murrell D, 2025, '65 Statin Therapy Is Associated With a Reduced Risk of Autoimmune Blistering Diseases: A Global Retrospective Cohort Study of 172 Million Individuals', Journal of Investigative Dermatology, 145, pp. e42, http://dx.doi.org/10.1016/j.jid.2025.09.083

Haag C; Alexis A; Aoki V; Bissonnette R; Blauvelt A; Chovatiya R; Cork MJ; Danby SG; Eichenfield LF; Eyerich K; Gooderham M; Guttman-Yassky E; Hijnen DJ; Irvine AD; Katoh N; Murrell DF; Leshem YA; Levin AA; Vittrup I; Olydam JI; Orfali RL; Paller AS; Renert-Yuval Y; Rosmarin D; Silverberg JI; Thyssen JP; Ständer S; Stefanovic N; Todd G; Yu JD; Simpson EL, 2024, 'A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council', British Journal of Dermatology, 192, pp. 135 - 143, http://dx.doi.org/10.1093/bjd/ljae342

Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D, 2024, '“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires', Italian Journal of Pediatrics, 50, http://dx.doi.org/10.1186/s13052-024-01657-2

Akbarialiabad H; Murrell DF, 2024, 'A new dawn for orphan diseases in dermatology: The transformative potential of digital twins', Journal of the European Academy of Dermatology and Venereology, 38, pp. 2309 - 2310, http://dx.doi.org/10.1111/jdv.20062

Akbarialiabad H; Pasdar A; Murrell DF, 2024, 'Digital twins in dermatology, current status, and the road ahead', Npj Digital Medicine, 7, http://dx.doi.org/10.1038/s41746-024-01220-7

Sarsam S; Murrell DF, 2024, 'Interleukin-17 inhibitors for the management of severe rosacea', Australasian Journal of Dermatology, 65, pp. 660 - 662, http://dx.doi.org/10.1111/ajd.14377

Werth VP; Murrell DF; Joly P; Heck R; Orengo JM; Ardeleanu M; Hultsch V, 2024, 'Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)', Advances in Therapy, 41, pp. 4418 - 4432, http://dx.doi.org/10.1007/s12325-024-02992-w

Victory L; Murrell DF, 2024, 'The future of digital pills and their potential use in dermatological clinical trials', Journal of the European Academy of Dermatology and Venereology, 38, pp. 2314 - 2315, http://dx.doi.org/10.1111/jdv.20224

Akbarialiabad H; Grant-Kels JM; Murrell DF, 2024, 'A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists', Clinics in Dermatology, 42, pp. 723 - 726, http://dx.doi.org/10.1016/j.clindermatol.2024.05.008

Tseng H; Stone C; Shulruf B; Murrell DF, 2024, 'Establishing minimal clinically important differences for the Pemphigus Disease Area Index', British Journal of Dermatology, 191, pp. 823 - 831, http://dx.doi.org/10.1093/bjd/ljae283

Kiritsi D; Schauer F; Gewert S; Reineker K; Reimer-Taschenbrecker A; Schwieger-Briel A; Ott H; Schmoor C; Grishina O; Murrell D; Stiller B; Zahn T; Nyström A; Bruckner-Tuderman L, 2024, 'Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial', Eclinicalmedicine, 77, http://dx.doi.org/10.1016/j.eclinm.2024.102900

Wong PC; Wang MA; Ng TJ; Akbarialiabad H; Murrell DF, 2024, 'Keratosis pilaris treatment paradigms: Assessing effectiveness across modalities', Clinical and Experimental Dermatology, 49, pp. 1105 - 1117, http://dx.doi.org/10.1093/ced/llae066

Back to profile page